The size of the Biochips Market in the Asia Pacific was worth USD 2.57 billion in 2020 and expected to grow at a CAGR of 22.94% to reach USD 7.21 billion by 2025 during the forecast period.
Asia pacific biochips market is growing at the fastest growth rate across all regions. Countries like India, China, and Japan have modern infrastructure and technology for the use of biochips in research and healthcare. The aging population in the Asia Pacific is significantly increasing, which is estimated to favor the market growth in this region.
The Asia Pacific region has a large number of the patient pool, which needs an early detection of the diseases, thus increasing the demand for the use of biochips. Furthermore, the rising number of biotech companies in this region and institutes researching the biomarkers for different diseases supports the Asia pacific biochips market growth. The governments of Asia pacific are funding for the development of biochip technology, a supporting factor for the market. The biochips are used in the next-generation sequencing and for the detection of biological warfare, further driving the market growth in the region.
The high costs associated and less awareness about the biochips technology are majorly restraining the market growth in this region. The availability of alternatives present in this region is a significant challenge for the companies operating in this region.
Asia Pacific Biochips Market segmented and sub-segmented into the following categories.
Based on the region, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to various reasons such as easy access to the latest technologies, a large patient pool, and promising government schemes. China and India are projected to be the fastest-growing markets in this region.
The Indian biochips market is estimated to showcase a robust CAGR during the forecast period. The Indian government is promoting the biotech and pharma sector companies, and many research institutes are using the biochip for research. Growing demand for personalized medicine and on-going research activities on genomics in India are further increasing the usage and demand for these products in this region.
Chinese biochips market covered the largest market share in the Asia Pacific region in 2019, and it is one of the leaders in the global biochips market. The Biochip Beijing National Engineering Research Center is promoting the research and development in the field of biochips. Various government initiatives to improve the usage of biochips are further accelerating the Chinese biochips market.
The Japanese biochips market is projected to grow at a healthy rate during the forecast period. This country has advanced technologies in the field of biochips, which is primarily propelling the market growth, but the patent law and regulatory bodies in Japan are very stringent.
Key Market Participants leading the Asia Pacific Biochips Market Profiled in the Report are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 DNA Chips
5.1.2.1 SNP Genotyping
5.1.2.2 Genomics
5.1.2.3 Agricultural Biotechnology
5.1.2.4 Gene Expression
5.1.2.5 Cancer Diagnosis & Treatment
5.1.2.6 Drug Discovery
5.1.2.7 Others
5.1.3 Lab-On-A-Chip
5.1.3.1 Clinical Diagnostics
5.1.3.2 IVD & POC
5.1.3.3 Drug Discovery
5.1.3.4 Genomics
5.1.3.5 Proteomics
5.1.4 Protein Chips
5.1.4.1 Expression Profiling
5.1.4.2 High-Throughput Screening
5.1.4.3 Proteomics
5.1.4.4 Diagnostics
5.1.4.5 Drug Discovery
5.1.5 Other types
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals and Diagnostics Centers
5.2.3 Biotechnology and Pharmaceutical Companies
5.2.4 Academic & Research Institutes
5.2.5 Y-o-Y Growth Analysis, By End User
5.2.6 Market Attractiveness Analysis, By End User
5.2.7 Market Share Analysis, By End User
5.3 Fabrication Technology
5.3.1 Introduction
5.3.2 Microfluidics
5.3.3 Microarrays
5.3.4 Y-o-Y Growth Analysis, By Fabrication Technology
5.3.5 Market Attractiveness Analysis, By Fabrication Technology
5.3.6 Market Share Analysis, By Fabrication Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By End User
6.1.3.4 By Fabrication Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By End User
6.1.4.4 By Fabrication Technology
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By End User
6.1.5.4 By Fabrication Technology
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Athersys
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Cryo Cell International
8.4 Geron Corporation
8.5 Mesoblast
8.6 Aastrom Biosciences
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
